<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>8484065</identifier>
<setSpec>0034-8376</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Kassack, J J</dc:author>
<dc:author>Arana-Trejo, R M</dc:author>
<dc:author>Cervantes-Peredo, A</dc:author>
<dc:author>Gutiérrez, M</dc:author>
<dc:author>Kofman-Alfaro, S</dc:author>
<dc:author>Rozen, E</dc:author>
<dc:description xml:lang="en">Between 1987 and 1990 cytogenetic studies of bone marrow and lymphocytes from peripheral blood from 25 patients with de novo ALL were performed. All cases had chromosomal aberrations; however in 23 patients a normal cell line was also present. The most important structural aberrations found were: t(17;19)(q11;p13), t(2;9;22)(q34;q34;11), t(1;7)(p13;q33), t(6;11)(q26;p16), t(3;4)(q24-25;q26), t(1;12)(q23;q34), t(2;18)(q15;p12), t(2;4)(q23;q35) and t(4;11)(q21;q23). These chromosome abnormalities correlate with the response to treatment and survival and improve the identification of high-risk patients. Our study shows the presence of some chromosomal abnormalities different to those reported in the literature; however the breakpoints involved seem to be the same which suggests that these critical regions may be directly involved in the pathogenesis of these disorders.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>1993 Jan-Feb </dc:date>
<dc:title xml:lang="es">Estudio citogenético en 22 adultos y tres niños con leucemia linfoblástica aguda.</dc:title>
<dc:title xml:lang="en">[Cytogenetic study of 22 adults and 3 children with acute lymphoblastic leukemia].</dc:title>
<dc:publisher>Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion</dc:publisher>
</metadata>
</record>
</pubmed-document>
